Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rich

Showing results (401-410 of 416) with videos related to

Pageof 42
Sort By:
Iscience|December 26, 2023
Sex differences in left-ventricular strain in a murine model of coxsackievirus B3 myocarditisDamian N Di Florio, Logan P Macomb, Presley G Giresi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Irinotecan therapy in adults with recurrent or progressive malignant gliomaH S Friedman, W P Petros, A H Friedman, et al.
Biorxiv : the Preprint Server for Biology|November 22, 2024
Association of oropharyngeal cancer recurrence with tumor-intrinsic and immune-mediated sequelae of reduced genomic instabilityMalay K Sannigrahi, Lovely Raghav, Dominick J Rich, et al.
ACS Chemical Biology|August 30, 2016
Structure of the Epigenetic Oncogene MMSET and Inhibition by N-Alkyl Sinefungin DerivativesDominic Tisi, Elisabetta Chiarparin, Emiliano Tamanini, et al.
BMC Public Health|November 5, 2021
Individual and poly-substance use and condomless sex among HIV-uninfected adults reporting heterosexual sex in a multi-site cohortR J Fredericksen, B M Whitney, E Trejo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 10, 2022
Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic MelanomaMacLean S Hall, John E Mullinax, Cheryl A Cox, et al.
Nature|December 16, 2005
The afterglow and elliptical host galaxy of the short gamma-ray burst GRB 050724E Berger, P A Price, S B Cenko, et al.
Journal for Immunotherapy of Cancer|October 6, 2023
Neoantigen-specific CD4<sup>+</sup> tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patientsMacLean S Hall, Jamie K Teer, Xiaoqing Yu, et al.
Molecular Cancer Therapeutics|July 31, 2021
ASTX029, a Novel Dual-mechanism ERK Inhibitor, Modulates Both the Phosphorylation and Catalytic Activity of ERKJoanne M Munck, Valerio Berdini, Luke Bevan, et al.
Journal of Medicinal Chemistry|April 1, 2016
Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based DiscoveryThomas G Davies, William E Wixted, Joseph E Coyle, et al.
Pageof 42

Showing results (401-410 of 416) with videos related to

Sort By:
Pageof 42
Iscience|December 26, 2023
Sex differences in left-ventricular strain in a murine model of coxsackievirus B3 myocarditisDamian N Di Florio, Logan P Macomb, Presley G Giresi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Irinotecan therapy in adults with recurrent or progressive malignant gliomaH S Friedman, W P Petros, A H Friedman, et al.
Biorxiv : the Preprint Server for Biology|November 22, 2024
Association of oropharyngeal cancer recurrence with tumor-intrinsic and immune-mediated sequelae of reduced genomic instabilityMalay K Sannigrahi, Lovely Raghav, Dominick J Rich, et al.
ACS Chemical Biology|August 30, 2016
Structure of the Epigenetic Oncogene MMSET and Inhibition by N-Alkyl Sinefungin DerivativesDominic Tisi, Elisabetta Chiarparin, Emiliano Tamanini, et al.
BMC Public Health|November 5, 2021
Individual and poly-substance use and condomless sex among HIV-uninfected adults reporting heterosexual sex in a multi-site cohortR J Fredericksen, B M Whitney, E Trejo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 10, 2022
Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic MelanomaMacLean S Hall, John E Mullinax, Cheryl A Cox, et al.
Nature|December 16, 2005
The afterglow and elliptical host galaxy of the short gamma-ray burst GRB 050724E Berger, P A Price, S B Cenko, et al.
Journal for Immunotherapy of Cancer|October 6, 2023
Neoantigen-specific CD4<sup>+</sup> tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patientsMacLean S Hall, Jamie K Teer, Xiaoqing Yu, et al.
Molecular Cancer Therapeutics|July 31, 2021
ASTX029, a Novel Dual-mechanism ERK Inhibitor, Modulates Both the Phosphorylation and Catalytic Activity of ERKJoanne M Munck, Valerio Berdini, Luke Bevan, et al.
Journal of Medicinal Chemistry|April 1, 2016
Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based DiscoveryThomas G Davies, William E Wixted, Joseph E Coyle, et al.
Pageof 42